1. Home
  2. TTMI vs RGEN Comparison

TTMI vs RGEN Comparison

Compare TTMI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TTM Technologies Inc.

TTMI

TTM Technologies Inc.

BUY

Current Price

$80.24

Market Cap

12.0B

Sector

Technology

ML Signal

BUY

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$176.25

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTMI
RGEN
Founded
1978
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
11.0B
IPO Year
2000
1995

Fundamental Metrics

Financial Performance
Metric
TTMI
RGEN
Price
$80.24
$176.25
Analyst Decision
Strong Buy
Buy
Analyst Count
5
22
Target Price
★ $211.00
$197.95
AVG Volume (30 Days)
★ 3.3M
1.2M
Earning Date
10-22-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
211.11
★ 286.96
EPS
★ 1.24
0.24
Revenue
★ $2,906,345,000.00
$141,236,000.00
Revenue This Year
$51.96
$12.87
Revenue Next Year
$32.48
$29.67
P/E Ratio
★ $60.02
$738.08
Revenue Growth
18.98
★ 35.10
52 Week Low
$55.44
$100.99
52 Week High
$223.83
$198.87

Technical Indicators

Market Signals
Indicator
TTMI
RGEN
Relative Strength Index (RSI) 32.79 48.53
Support Level N/A $158.62
Resistance Level $110.58 $187.36
Average True Range (ATR) 8.52 8.73
MACD -3.93 -0.36
Stochastic Oscillator 12.43 49.63

Price Performance

Historical Comparison
TTMI
RGEN

About TTMI TTM Technologies Inc.

TTM Technologies Inc manufactures technology products, including mission systems, RF components, RF/microwave assemblies, and advanced interconnect products such as PCBs and substrates. It operates through three segments: A&D, Commercial, and RF&S Components. The A&D segment supports aerospace and defense missions with PCBs, assemblies, microelectronics, and integrated systems. The Commercial segment, generating the majority of revenue, serves automotive, medical, industrial, and data center markets. The RF&S Components segment provides TTM-designed RF components and COTS products. The Company's revenues come from PCBs, engineered systems, and long-term contracts for intelligence, surveillance, and communications solutions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: